Health
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
Allergan Aesthetics, an AbbVie company, will present 21 scientific e-posters at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco on March 26-28, 2026, underscoring the company's industry leadership in advancing patient-centric, evidence-based innovation across the spectrum of aesthetics medicine. The data span clinical, real-world and preclinical research, reflecting a deep commitment to driving exceptional results, safety and satisfaction for practitioners and patients worldw
About this update from Abbvie Inc.
[{"type":"text","content":"- Five scientific e-posters highlight investigational neurotoxin trenibotulinumtoxinE (TrenibotE), demonstrating rapid improvement in glabellar lines (as early as 8 hours), robust and consistent efficacy, and a favorable safety profile across global patient populations","length":269,"tagName":"p"},{"type":"text","content":"- Real-world and clinical data reinforce onabotulinumtoxinA (BOTOX® Cosmetic) as a foundation for high patient satisfaction, natural-looking results, and the gateway to multimodal facial aesthetic treatment plans","length":212,"tagName":"p"},{"type":"text","content":"- Portfolio-wide results demonstrate continued investment in innovative, integrated approaches for patients and practitioners ","length":125,"tagName":"p"},{"type":"text","content":"NORTH CHICAGO, Ill., March 26, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, will present 21 scientific e-posters at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco on March 26-28, 2026, underscoring the company's industry leadership in advancing patient-centric, evidence-based innovation across the spectrum of aesthetics medicine. The data span clinical, real-world and preclinical research, reflecting a deep commitment to driving exceptional results, safety and satisfaction for practitioners and patients worldwide.","length":564,"tagName":"p"},{"type":"text","content":""At Allergan Aesthetics, our progress is driven by a dedication to generating high-quality scientific data that informs every advance we bring to aesthetic medicine," said Darin Messina, Ph.D., senior vice president, research & development, Allergan Aesthetics. "The breadth and depth of findings presented at AMWC Monaco demonstrate our commitment to equipping practitioners with meaningful scientific insights and innovative solutions, all aimed at delivering safe, effective and individualized outcomes for patients."","length":544,"tagName":"p"},{"type":"text","content":"Investigational Neurotoxin TrenibotulinumtoxinE Demonstrates Rapid Results as Early as 8 Hours and Short Duration with Consistent Efficacy and Safety Research shows that investigational neurotoxin trenibotulinumtoxinE (TrenibotE) delivers rapid results as early as 8 hours, a short duration of 2-3 weeks, and consistent efficacy with safety observed across diverse ...